Home|Journals|Articles by Year|Audio Abstracts

Case Report

Severe acute urinary retention requiring urinary catheterization in a young female patient using duloxetine: A case report

Mikail Burak Aydin, Yasemin Erken, Ibrahim Gundogmus, Aysegul Tasdelen Kul.

Cited by 0 Articles

Side effects are one of the most important obstacles to the use of psychotropic drugs. Although duloxetine, commonly used in clinical practice, is known to be an effective and reliable antidepressant, it is known to cause some side effects. Although it has been reported in the literature that urinary side effects such as urination difficulties and frequent urination may be encountered, especially in men, it is very rare in women. Urinary retention is defined that is sudden onset of inability to void or presence of important amount of postmicturitional residual urine. It has been reported that drug-induced urinary retention may be associated with psychotropic drugs such as olanzapine, sertraline, aripiprazole and duloxetine in the literature. The cases associated with duloxetine were generally seen in combination form and with organic pathologies. As far as we know, the young female patient who has no organic pathology has no urinary retention associated with the use of duloxetine. In this report, we present a young female patient who had a 32-year-old without organic disease who developed urinary retention requiring urinary catheterization after the use of duloxetine.

Key words: Aantidepressant; case report; duloxetine; female; side effect, urinary retention.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.